Type 2 Diabetic Sepsis Patients Have a Lower Mortality Rate in Pioglitazone Use: A Nationwide 15-Year Propensity Score Matching Observational Study in Taiwan.
Ming-Shun HsiehSung-Yuan HuShu-Hui LiaoChia-Ming ChangVivian Chia-Rong HsiehChorng-Kuang HowPublished in: Emergency medicine international (2021)
This first human cohort study demonstrated the potential protective effect of chronic pioglitazone use in type 2 diabetic sepsis patients.